scholarly journals Role of Gamma Glutamyl Transferase in the Diagnosis of Metabolic Syndrome in Patients with Hypothyroidism

2019 ◽  
Author(s):  
ME Sumathi ◽  
K Prabhavathi ◽  
S Harish Kumar ◽  
KN Shashidhar ◽  
V Mahesh
Keyword(s):  
Metabolic Syndrome ◽  
Gamma Glutamyl Transferase ◽  
Gamma Glutamyl ◽  
Glutamyl Transferase

scholarly journals Role of gamma glutamyl transferase as a diagnostic marker of metabolic syndrome

2019 ◽  
Vol 5 (3) ◽  
pp. 122-126
Author(s):  
Sangamesh Asuti ◽  
◽  
Abhinay Tibdewal ◽  
Arun Narayan ◽  
◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Diagnostic Marker ◽  
Gamma Glutamyl Transferase ◽  
Gamma Glutamyl ◽  
Glutamyl Transferase

scholarly journals Role of C-reactive protein and gamma-glutamyl transferase in the diagnosis of metabolic syndrome

2021 ◽  
Vol 9 (4) ◽  
pp. 118-124
Author(s):  
Rubina Ghani ◽  
◽  
Mozaffer Rahim Hingorjo ◽  
Samia Perwaiz Khan ◽  
Uzma Naseeb ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Metabolic Syndrome ◽  
General Population ◽  
Gamma Glutamyl Transferase ◽  
C Reactive Protein ◽  
Gamma Glutamyl ◽  
Reactive Protein ◽  
Increased Risk ◽  
Glutamyl Transferase

Previous studies have reported that metabolic syndrome (MetS) is associated with an increased risk of major cardiovascular events and levels of C-Reactive protein (CRP) can be considered as markers of MetS and its constituent components. Oxidative stress plays a major role in the development of MetS, and levels of gamma-glutamyl transferase (GGT) change with response to oxidative stress are also associated with MetS, which may be modulated by CRP. This study was conducted to identify the role of GGT and CRP as biomarkers in the diagnosis of MetS, a high-risk factor for cardiovascular diseases. One hundred and fifty patients meeting the diagnostic criteria of MetS and an equal number of controls were included in the study. The cases were selected from pathology and molecular biology laboratories, Karachi, while the controls came from the general population. Anthropometric indices of adiposity and blood pressure were recorded for both cases and controls. Blood samples were taken from all subjects to determine the levels of CRP and GGT. All those cases and control height, weight, hip waist circumference were noted and the comparison of CRP and GGT by applying students' t-test as markers for detection of metabolic syndrome. p-value 0.001 was considered as significant. This study suggests that in patients with metabolic syndrome were found to have raised the basal metabolic rate, C-reactive protein and GGT were synergistically associated with MetS independently of another confounding factor in the general population. Keywords: C-reactive protein (CRP), gama glutamyl transferase (GGT), metabolic syndrome, (Met-S), inflammation, body mass index.

scholarly journals ASSOCIATION OF GAMMA-GLUTAMYL TRANSFERASE WITH METABOLIC SYNDROME

2016 ◽  
Vol 3 (100) ◽  
pp. 5498-5502
Author(s):  
Vijayalakshmi Masilamani ◽  
Poonguzhali Gopinath ◽  
Sangeetha Kandasamy ◽  
Aravind Kumar
Keyword(s):  
Metabolic Syndrome ◽  
Gamma Glutamyl Transferase ◽  
Gamma Glutamyl ◽  
Glutamyl Transferase

scholarly journals Gamma glutamyl transferase – an underestimated marker for cardiovascular disease and the metabolic syndrome

2020 ◽  
Vol 23 (1) ◽  
pp. 65-74
Author(s):  
Manuela G Neuman ◽  
Stephen Malnick ◽  
Lucy Chertin
Keyword(s):  
Heart Failure ◽  
Cardiovascular Disease ◽  
Metabolic Syndrome ◽  
Gamma Glutamyl Transferase ◽  
Gamma Glutamyl ◽  
The Metabolic Syndrome ◽  
Obstructive Sleep ◽  
Tract Involvement ◽  
Glutamyl Transferase ◽  
Enzyme Test

Gamma glutamyl transferase (GGT) is an enzyme in glutathione and cysteine metabolism. GGT is a standard liver enzyme test reflecting biliary tract involvement. It also has a prooxoidant activity and a modulating influence on endothelia dysfunction. GGT is associated with the metabolic syndrome and is often elevated in patients with NAFLD. There is also a role for GGT activity in several aspects cardiovascular disease. There is an association between elevated GGT and cardiovascular mortality, atrial fibrillation, exacerbation of congestive heart failure . In addition there is an association with obstructive sleep apnea. We review the evidence available and suggest that there is a need for further assessing the use of GGT, together with the presence of the metabolic syndrome as a prognostic marker.

Sign in / Sign up

Export Citation Format

Share Document